Thursday's Insider Activity: Top Buys and Sells in US Stocks

US equities saw significant insider trading activity on July 10, 2025, marked by substantial insider selling across several major tech and biotech firms. CEOs and directors at Cloudflare, Halozyme Therapeutics, Nvidia Corp (two separate transactions totaling over $60M), and Samsara Inc. collectively sold tens of millions of dollars in shares, with some sales pre-arranged under 10b5-1 plans. In contrast, notable insider buying occurred at CalciMedica, where a director purchased shares following a 46% stock decline, and at RENN Fund and Texas Pacific Land Corp, signaling varied insider sentiment.

Analysis

A significant divergence in insider trading activity was observed on July 10, 2025, highlighting a potential sentiment split between high-growth technology names and other market segments. Substantial insider selling occurred across several major tech and biotech firms, most notably at Nvidia (NVDA), where the CEO and a director collectively sold over $60.4 million worth of stock. Similarly, CEOs at Cloudflare (NET), Halozyme Therapeutics (HALO), and Samsara (IOT) executed multi-million dollar sales. While the sales at Halozyme and Nvidia were conducted under pre-arranged 10b5-1 trading plans, which can be part of regular financial planning, the sheer volume and concentration of selling by top executives could suggest a view that valuations are peaking. In contrast, insider buying activity, though smaller in absolute dollar terms, was strategically notable. A director at CalciMedica (CALC) purchased shares after a 46% stock price decline over six months, indicating a potential contrarian bet on value. The president of RENN Fund (RCG) added to his position despite the stock's 56% gain in the past year, signaling continued confidence. Finally, a major owner's purchase at Texas Pacific Land (TPL), while nominal, draws attention to the company's robust fundamentals, including 93.5% gross profit margins and a 12-year dividend payment history.

Key Decisions for Investors

• Investors in high-flying tech stocks like Nvidia, Cloudflare, and Samsara should note the significant profit-taking by C-suite executives, which could be a signal to review position sizing and risk exposure.
• The pre-arranged nature of the sales at Halozyme and Nvidia (10b5-1 plans) mitigates some of the negative sentiment, but the high volume still warrants monitoring these stocks for any signs of price momentum shifts or fundamental changes.
• The director's purchase at CalciMedica following a steep 46% decline presents a potential contrarian opportunity, justifying further due diligence for investors with a higher risk tolerance.
• The continued insider buying at RENN Fund and the fundamental strength highlighted at Texas Pacific Land Corp suggest these names may warrant consideration for investors seeking either momentum or long-term quality, respectively.